STARPHARMA HOLDINGS LIMITED - Charts / Financials

18.2%

13.0¢

Market Cap $54.36M

Healthcare Biotechnology

Starpharma Holdings Limited is an Australia-based biotechnology company. The principal... Starpharma Holdings Limited is an Australia-based biotechnology company. The principal activities of the Company consist of research, development and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its portfolio of dendrimer-based products includes three clinical-stage DEP (dendrimer enhanced product) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over-the-counter (OTC) products. It has developed a pipeline of novel DEP oncology products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, it has a preclinical pipeline of DEP radiopharmaceuticals and DEP Antibody-Drug Conjugates (ADCs) in development. Its VIRALEZE Nasal Spray is a broad-spectrum nasal spray intended to provide a protective barrier in the nose that traps and blocks cold/respiratory viruses. It also offers VivaGel BV and VivaGel Condom products. More

Day
Open	11.5¢		Day High	13.5¢		Day Low	11.0¢
Daily Volume	200402

Bids		Sellers
Number	Price	Volume		Number	Price	Volume
1	13.0¢	617923		7	13.5¢	108845

Directors & Senior Management

Ms. Cheryl Maley	Chief Executive Officer, Managing Director, Director
Mr. Justin W. Cahill	Chief Financial Officer, Company Secretary
Mr. Robert Bain Thomas	Independent Non-Executive Chairman of the Board
Dr. Russell Basser	Independent Non-Executive Director
Ms. Lynda Cheng	Independent Non-Executive Director
Dr. Jeff R. Davies	Independent Non-Executive Director
Mr. David John Mcintyre	Independent Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 13.0¢		Change 0.020(18.2%)		Mkt cap ! $54.36M

Open	High	Low	Value	Volume
11.5¢	13.5¢	11.0¢	$25.52K	200.4K

Buyers (Bids)

No.	Vol.	Price($)
1	617923	13.0¢

Sellers (Offers)

Price($)	Vol.	No.
13.5¢	108845	7

View Market Depth

No.	Vol.	Price($)
1	617923	0.130
2	56308	0.125
1	50000	0.120
1	43350	0.115
3	13597	0.110

Price($)	Vol.	No.
0.135	102840	6
0.140	161341	4
0.145	112695	8
0.150	175000	3
0.155	50000	1

Last trade - 16.10pm 04/09/2025 (20 minute delay)


Last 13.5¢		Change 0.020 ( 20.0 %)
Open	High	Low	Volume
11.3¢	13.5¢	11.3¢	186899
Last updated 16.00pm 04/09/2025 ?

SPL (ASX) Chart

STARPHARMA HOLDINGS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories